Well we don't know whether the patient with 'zero tumour burden' is that yellow line on the graph. I stated that the person is likely the one who achieved a CR. This graph just tells us about antibodies and we know there are only 7 lines. We know that 3 people are still living and are on the trial, however only 1 of the lines runs all the way to the end at 42 weeks. Given that the graph is aiming to demonstrate that a there is a correlation between dosage and antibody production between each of the arms, I think it does a good job at depicting that.
Remember our objectives in a phase 1 trial.
You're missing that every patient in the trial was in 1 of the monotherapy treatment arms, all with varying levels of IMU-201 (PD1-Vaxx), with no other treatment. So the only conclusion would be that the patient on the trial has had a health benefit from PD1-Vaxx and their immune system has been able to kill off the tumour with no reoccurrence 18months later.
Remember to be eligible for the trial, all patients needed to:
1. Histologically confirmed non-small-cell lung cancer (NSCLC) tumor stage IIIb or IV (3 major types of NSCLC are acceptable including squamous, adenocarcinoma, and large cell carcinoma);
2. Progressed on an approved PD-1 inhibitor or an approved PD-L1 inhibitor. Patients previously treated with a combination of an approved PD-1 or an approved anti-PD-L1 inhibitor and chemotherapy may be included with agreement of Imugene Limited
Sourced from A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer - Full Text View - ClinicalTrials.gov
- Forums
- ASX - By Stock
- Ann: Imugene Presents New PD1-Vaxx Data at the 2022 WCLC
Well we don't know whether the patient with 'zero tumour burden'...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.2¢ |
Change
0.003(5.08%) |
Mkt cap ! $455.6M |
Open | High | Low | Value | Volume |
5.8¢ | 6.5¢ | 5.7¢ | $1.751M | 28.44M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 660964 | 6.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.2¢ | 549788 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 320000 | 0.061 |
8 | 435316 | 0.060 |
2 | 165000 | 0.059 |
7 | 1686333 | 0.058 |
6 | 1100000 | 0.057 |
Price($) | Vol. | No. |
---|---|---|
0.064 | 100000 | 1 |
0.065 | 428308 | 6 |
0.066 | 1116000 | 5 |
0.067 | 1247888 | 2 |
0.068 | 3350000 | 5 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online